Prescient Therapeutics (ASX-PTX)
Live Investor Briefing
Thursday, 1st October at 11am (AEST)
Please join us for a special investor briefing with Prescient Therapeutics CEO and MD Steven Yatomi-Clarke.
Steven will discuss:
- The company’s promising pipeline of cancer treatments with two targeted therapies, cell therapy enhancements and CAR-T
- Its work in the most exciting area of cancer research “next gen” CAR-T and its OmniCAR platform
- Strong balance sheet with $20m in the bank following oversubscribed Share Purchase Plan and Placement
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.